Expression of New York esophageal squamous cell carcinoma-1 in primary and metastatic melanoma-Reference-Cited by-同舟云学术

Expression of New York esophageal squamous cell carcinoma-1 in primary and metastatic melanoma

Published:2014-02 Issue:2 Volume:45 Page:259-267
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Aung Phyu P.,Liu Yen-Chun,Ballester Leomar Y.,Robbins Paul F.,Rosenberg Steven A.,Lee Chyi-Chia Richard

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference19 articles.

1. Use of immunohistochemistry in the diagnosis of melanocytic lesions: applications and pitfalls;Ivan;Future Oncol,2010

2. Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM): correlation with prognostic factors;Velazquez;Cancer Immun,2007

3. Melanoma or not? Cancer testis antigens may help;Lüftl;Br J Dermatol,2004

4. Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1;Robbins;J Clin Oncol,2011

5. NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1–based targeted therapy and differential diagnosis;Lai;Mod Pathol,2012

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potentially actionable targets in synovial sarcoma: A tissue microarray study;Translational Oncology;2024-10

2. TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors;Biomedicines;2023-10-16

3. The molecular mechanisms of apoptosis accompanied with the epigenetic regulation of the NY-ESO-1 antigen in non-small lung cancer cells treated with decitabine (5-aza-CdR);European Journal of Pharmacology;2023-04

4. Paving the Way to Solid Tumors: Challenges and Strategies for Adoptively Transferred Transgenic T Cells in the Tumor Microenvironment;Cancers;2022-08-29

5. TIE-2 Signaling Activation by Angiopoietin 2 On Myeloid-Derived Suppressor Cells Promotes Melanoma-Specific T-cell Inhibition;Frontiers in Immunology;2022-07-22